Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study.
Zhang WP, Wang ZW, Hu XX, Chen J, Yang D, Song XM, Gao L, Ni X, Chen L, Xia XX, Zhou H, Tang GS, Cheng H, Luo YR, Li HM, Yang JM, Wang JM.
Zhang WP, et al. Among authors: wang zw, wang jm.
Bone Marrow Transplant. 2019 Jun;54(6):894-902. doi: 10.1038/s41409-018-0356-5. Epub 2018 Oct 19.
Bone Marrow Transplant. 2019.
PMID: 30337697
Clinical Trial.